NERON AI uses novel digital technology to measure brain performance - Canadian Healthcare Technology
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
Toronto-based NERON AI, a startup company, has created a computer-based system that measures brain performance through exercises that test the brain’s neuromotor control – how a person simultaneously moves and thinks.
The system is sensitive enough to spot the onset of dementia years before a standard clinical diagnosis – using an on-screen test that takes about 10 minutes.
This article is an excerpt. To read the full content, visit the original source. Canadian Healthcare Technology
Related articles

Amazon deal has shaved 33% off this popular TP-Link WiFi 7 router - PC Guide
Upgrading to a WiFi 7 router just got easier PC Guide is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Read More

Today’s NYT Strands Hints, Spangram and Answers for Sunday, Oct. 18, #959 - CNET
Here’s your NYT Strands hint for today, plus the spangram and all of today’s Strands answers for puzzle No. 959 on Sunday, Oct. 18, 2026. Today’s Strands theme was tricky. It helps to be a runner. Read on for all the answers.

WARNING: ConnectWise Supply-Chain Attack Exposes Microsoft 365 Tenants - LinkedIn
A supply-chain attack involving ConnectWise’s cloud services has exposed Microsoft 365 customers to unauthorized application access, with researchers reporting successful sign-ins across 173 partner and customer tenants. The incident centres on credentials associated with ConnectWise Cloud Backup, formerly SkyKick, and raises concerns about attackers exploiting permissions already entrusted to business software. ConnectWise has confirmed unauthorized access to application identities within its Cloud Backup environment. In an October 17 update on its service-status page, the company said it was shutting off application access, interrupting customer backups while investigation and remediation continued.
0 comments
No comments yet. Be the first to share your thoughts!